Suppr超能文献

可溶性白细胞介素-1 Ⅱ型受体-免疫球蛋白融合蛋白的基因转移可提高大鼠心脏移植的存活率。

Gene transfer of a soluble IL-1 type 2 receptor-Ig fusion protein improves cardiac allograft survival in rats.

作者信息

Simeoni Eleonora, Dudler Jean, Fleury Sylvain, Li Jianping, Pagnotta Maria, Pascual Manuel, von Segesser Ludwig K, Vassalli Giuseppe

机构信息

Department of Cardiology, University of Lausanne Medical School, Lausanne, Switzerland.

出版信息

Eur J Cardiothorac Surg. 2007 Feb;31(2):222-8. doi: 10.1016/j.ejcts.2006.10.042. Epub 2006 Dec 19.

Abstract

OBJECTIVE

Interleukin-1 (IL-1) mediates ischemia-reperfusion injury and graft inflammation after heart transplantation. IL-1 affects target cells through two distinct types of transmembrane receptors, type-1 receptor (IL-1R1), which transduces the signal, and the non-signaling type-2 receptor (IL-1R2), which acts as a ligand sink that subtracts IL-1beta from IL-1R1. We analyzed the efficacy of adenovirus (Ad)-mediated gene transfer of a soluble IL-1R2-Ig fusion protein in delaying cardiac allograft rejection and the mechanisms underlying the protective effect.

METHODS

IL-1 inhibition by IL-1R2-Ig was tested using an in vitro functional assay whereby endothelial cells preincubated with AdIL-1R2-Ig or control virus were stimulated with recombinant IL-1beta or tumor necrosis factor-alpha (TNF-alpha), and urokinase-type plasminogen activator (u-PA) induction was measured by zymography. AdIL-1R2-Ig was delivered to F344 rat donor hearts ex vivo, which were placed in the abdominal position in LEW hosts. Intragraft inflammatory cell infiltrates and proinflammatory cytokine expression were analyzed by immunohistochemistry and real-time reverse transcriptase-polymerase chain reaction (RT-PCR), respectively.

RESULTS

IL-1R2-Ig specifically inhibited IL-1beta-induced u-PA responses in vitro. IL-1R2-Ig gene transfer reduced intragraft monocytes/macrophages and CD4(+) cell infiltrates (p<0.05), TNF-alpha and transforming growth factor-beta (TGF-beta) expression (p<0.05), and prolonged graft survival (15.6+/-5.7 vs 10.3+/-2.5 days with control vector and 10.1+/-2.1 days with buffer alone; p<0.01). AdIL-1R2-Ig combined with a subtherapeutic regimen of cyclosporin A (CsA) was superior to CsA alone (19.4+/-3.0 vs 15.9+/-1.8 days; p<0.05).

CONCLUSIONS

Soluble IL-1 type-2 receptor gene transfer attenuates cardiac allograft rejection in a rat model. IL-1 inhibition may be useful as an adjuvant therapy in heart transplantation.

摘要

目的

白细胞介素-1(IL-1)介导心脏移植后的缺血再灌注损伤和移植物炎症。IL-1通过两种不同类型的跨膜受体影响靶细胞,即转导信号的1型受体(IL-1R1)和作为配体库从IL-1R1中减去IL-1β的无信号传导功能的2型受体(IL-1R2)。我们分析了腺病毒(Ad)介导的可溶性IL-1R2-Ig融合蛋白基因转移在延迟心脏同种异体移植排斥反应中的疗效及其保护作用的潜在机制。

方法

使用体外功能试验检测IL-1R2-Ig对IL-1的抑制作用,即用AdIL-1R2-Ig或对照病毒预孵育的内皮细胞,再用重组IL-1β或肿瘤坏死因子-α(TNF-α)刺激,通过酶谱法检测尿激酶型纤溶酶原激活剂(u-PA)的诱导情况。将AdIL-1R2-Ig离体导入F344大鼠供心,然后将其置于LEW受体的腹部位置。分别通过免疫组织化学和实时逆转录聚合酶链反应(RT-PCR)分析移植物内炎性细胞浸润和促炎细胞因子表达。

结果

IL-1R2-Ig在体外特异性抑制IL-1β诱导的u-PA反应。IL-1R2-Ig基因转移减少了移植物内单核细胞/巨噬细胞和CD4(+)细胞浸润(p<0.05)、TNF-α和转化生长因子-β(TGF-β)表达(p<0.05),并延长了移植物存活时间(分别为15.6±5.7天、对照载体组为10.3±2.5天、单独缓冲液组为10.1±2.1天;p<0.01)。AdIL-1R2-Ig与环孢素A(CsA)的亚治疗方案联合使用优于单独使用CsA(分别为19.4±3.0天和15.9±1.8天;p<0.05)。

结论

可溶性IL-1 2型受体基因转移可减轻大鼠模型中的心脏同种异体移植排斥反应。抑制IL-1可能作为心脏移植的辅助治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验